Palladone (Hydromorphone Hydrochloride)

Hydromorphone hydrochloride, the active ingredient in Palladone, is an opioid analgesic presented as a strength/form for oral use. It is indicated for the management of moderate to severe pain in adult patients when alternative treatments are inadequate.

GNH USA supplies Palladone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydromorphone hydrochloride is an opioid that acts on the central nervous system to relieve pain across several clinical settings. - Acute postoperative pain: provides rapid analgesia following surgical procedures. - Cancer‑related pain: helps control persistent pain associated with malignant disease. - Severe chronic non‑cancer pain: used when other analgesics are insufficient.

Adverse reactions to hydromorphone may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Constipation: reduced bowel motility. - Drowsiness: increased sleepiness. - Dizziness: light‑headed sensation. - Dry mouth: reduced salivation. - Sweating: increased perspiration.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing. - Severe hypotension: marked drop in blood pressure. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Dependence or withdrawal: signs of physical dependence with prolonged use. - Confusion or delirium: altered mental status. - Urinary retention: difficulty emptying the bladder.

When prescribing hydromorphone, clinicians should assess patient history and monitor for adverse effects. - Assess renal and hepatic function: adjust dosing in impairment. - Evaluate respiratory status: avoid use in patients with compromised breathing. - Review concomitant CNS depressants: increased risk of sedation and respiratory depression. - Monitor for signs of dependence: educate patients on proper use. - Use caution in the elderly: increased sensitivity to opioid effects. - Store at ambient temperature: keep in original container, protect from moisture and light.

Hydromorphone may interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Benzodiazepines: combined use can cause profound respiratory depression. - Barbiturates: additive CNS depression increases overdose risk. - Muscle relaxants: may enhance sedative effects.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase serotonin levels, raising serotonin syndrome risk. - Antihistamines: can augment drowsiness. - Anticonvulsants: may alter opioid metabolism. - Alcohol: potentiates central nervous system depression.